Biochemical characterization of muscle tissue of limb girdle muscular dystrophy: An 1H and 13 C NMR study

NMR in Biomedicine

Volumn 16, Issue 4, 2003, Pages 213-223

  Sharma, Uma ^a   Atri, Surinder ^a   Sharma, M C ^a   Sarkar, Chitra ^a   Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Concentration of metabolites; in vitro; LGMD; Metabolism; PCA extraction; Proton nuclear magnetic resonance spectroscopy; Skeletal muscle

Indexed keywords

BIOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; TISSUE;

MUSCLE TISSUES;

MUSCLE;

ALANINE; AMINO ACID; CHOLINE; GLUCOSE; GLUTAMINE; LACTIC ACID; PERCHLORIC ACID;

ANAEROBIC GLYCOLYSIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE BIOPSY; MUSCLE METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETER;

AMINO ACIDS; ANIMALS; CELL MEMBRANE; GLUCOSE; HUMANS; LACTIC ACID; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEOTIDES; TISSUE EXTRACTS;

EID: 0142062463     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.832     Document Type: Article

References (40)

1. World Federation of Neurology Research Committee Research Group on Neuromuscular Diseases. J. Neurol. Sci. 1988; 86: 330-360.
2. Nishio T, Sunohara N, Nonaka I, Tsujino S, Sugie H. Myophosphorylase deficiency and limb girdle dystrophy in the same pedigree. Acta Neurol. Scand. 1998; 98: 364-367.
3. 31P MR spectroscopy indicating a multisystem mitochondrial defect. J. Neurol. Sci. 1996; 137: 20-27.
4. 31P MRS) in neuromuscular disorders. Ann. Neurol. 1991; 30: 90-97.
5. Argov Z, Lofberg M, Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle and Nerve 2000; 23: 1316-1334.
6. Arnold DL, Taylor DJ, Radda, GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann. Neurol. 1985; 18: 189-196.
7. 31P magnetic resonance and biochemical investigation. J. Neurol. Sci. 1985; 71: 105-118.
8. Venkatasubramanian PN, Arus C, Barany M. Two-dimensional proton magnetic resonance of human muscle extracts. Clin. Physiol. Biochem. 1986; 4: 1-7.
9. 1H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal. Biochem. 2001; 293: 16-21.
10. Cheng LL, Chang IW, Smith BL, Gonzalez RG. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J. Magn. Reson. 1998; 135: 194-202.
11. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994; 7: 181-194.
12. 1H NMR of acid extracts. Biochim. Biophys. Acta 1991; 1054: 181-197.
13. 1H NMR spectrostudies of liver extracts of carbon tetrachloride treated rats. NMR Biomed. 1999; 12: 395-401.
14. Boss EA, Moolenaar SH, Leon FA, Massuger AG, Boonstra H, Engleke UFH, Jong JGN, Wevers RA. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed. 2000; 13: 297-305.
15. 1H NMR spectroscopy of blood plasma for metabolic studies. Clin. Chem. 1994: 40: 1245-1250.
16. Patel AB, Srivastava S, Phadke RS, Govil G. Identification of low molecular weight compounds in goat epididymis using multinuclear nuclear magnetic resonance. Anal. Biochem. 1999; 266: 205-215.
17. 31P magnetic resonance spectroscopy of muscle extracts in malignant hyperthermia susceptible patients. Anesthesiology 1996; 84: 1077-1082.
18. Sharma U, Chaudhury K, Jagannathan NR, Guha SK. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction 2001; 122: 431-436.
19. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand. J. Clin. Lab. Invest. 1974; 33: 109-120.
20. Rennie MJ. Leucine metabolism in skeletal muscle and whole body in normal man and patients with muscle diseases. In Neuromuscular Diseases, Serratice G, Cros D, Desnuelle C, Gastaut JL, Pellissier JF, Pouget J, Schiano A (eds). Raven Press: New York, 1984; 37-44.
21. Harris RC, Hultman E. Muscle phosphagen status studied by needle biopsy. In Energy Metabolism: Tissue Determinants and Cellular Corollaries, Kinney JM, Tucker HN (eds). Raven Press: New York. 1992; 367-379.
22. Soderlund K, Hultman E. Effects of delayed freezing on content of phosphagens in human skeletal muscle biopsy samples. J. Appl. Physiol. 1986; 61: 832-835.
23. Nurjhan N, Bucci A, Perriello G. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J. Clin. Invest. 1995; 95: 272-277.
24. Hankard R, Haymond M, Darmaun D. Role of glutamine as a glucose precursor in fasting humans. Diabetes 1997; 46: 1535-1541.
25. Nishio H, Wada H, Matsuo T, Harikawa H, Takahashi K, Nakajima T, Matsuo M, Nakamuro H. Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev. 1990; 12: 390-402.
26. Ibrahim GA, Zweber BA, Essam BA, Awad A. Muscle and serum enzymes and isoenzymes in muscular dystrophies. Arch. Phys. Med. Rehabil. 1981; 62: 265-269.
27. 31P magnetic resonance spectroscopy study. Brain 1999; 122: 121-130.
28. Drefus JC, Schapira G, Schapira F, Demos J. Activites enzymatiques du muscle humain: recherches sur la bichimie comparee de l' homme normal et myopathique et du rat. Clin. Chim. Acta 1956; 1: 434-449.
29. Ellis DA. Intermediary metabolism of muscle in Duchenne muscular dystrophy. Br. Med. Bull. 1980; 36: 165-171.
30. 1H NMR spectroscopic characterization of muscle tissue extracts in Duchenne muscular dystrophy patients. Proc. Int. Soc. Magn. Reson. Med. 2002; 10: 2187.
31. 31P NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J. Neurol. Sci. 1992; 109: 188-195.
32. 31P NMR studies in Duchenne muscular dystrophy: age related metabolic changes. Neurology 1987; 37: 165-169.
33. Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J. Neurol. Sci. 1993; 116: 201-206.
34. Agris PF, Campbell ID. Proton nuclear magnetic resonance of intact Freund leukemia cells: phosphorylcholine increase during differentiation, Science 1982; 216: 1325-1327.
35. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br. J. Cancer 2001; 84: 1016-1022.
36. Jagannathan NR, Wadhwa S. In-vivo proton magnetic resonance spectroscopy (MRS) study of post polio residual paralysis (PPRP) patients. Magn. Reson. Imag. 2002; 20: 113-117.
37. McIntosh LM, Garret KL, Megeney L, Rudnicki MA, Anderson JE. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat. Rec. 1998; 252: 311-324.
38. 2+ is elevated at all ages. J. Neurol. Sci. 1991; 103: 226-231.
39. Berridge MJ. Inositol phosphate as second messengers. Biochem. J. 1984; 220: 345-360.
40. Sharma U, Atri S, Sharma MC, Sarkar C, Jagannathan NR. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in vitro proton NMR spectroscopy study. Magn. Reson. Imag. 2003; 21: 145-153.